TCT-509 Eighteen-month results of high-risk patients treated with ultrathin-strut biodegradable-polymer Orsiro DES. The Bioflow-III Satellite Italy Subgroups analysis.

Stefano Galli,Francesco Versaci,Carlo Briguori,Fabrizio Tomai,Arnaldo Poli,Carlo Vigna,Luigi My,Filippo Masi,Maurizio Turturo,Antonio L. Bartorelli

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 0|浏览30

暂无评分

摘要

Thin-strut biodegradable-polymer DES (Orsiro), a new generation DES, shows a performance similar to last generation DES and very low LLL if compared with everolimus-eluting stents in general population. We aimed to evaluate global performance in high-risk subgroups: diabetics, AMI and small vessels

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要